| 000 | 01643 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513153952.0 | ||
| 264 | 0 | _c19981113 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0022-2143 | ||
| 024 | 7 |
_a10.1016/s0022-2143(98)90047-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDouma, C E | |
| 245 | 0 | 0 |
_aAre phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? _h[electronic resource] |
| 260 |
_bThe Journal of laboratory and clinical medicine _cOct 1998 |
||
| 300 |
_a329-40 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aBlood Flow Velocity |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 |
_aCyclic GMP _xanalysis |
| 650 | 0 | 4 |
_aDinoprostone _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitric Oxide _xanalysis |
| 650 | 0 | 4 |
_aPeritoneal Dialysis, Continuous Ambulatory _xadverse effects |
| 650 | 0 | 4 |
_aPeritoneum _xmetabolism |
| 650 | 0 | 4 |
_aPeritonitis _xetiology |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 |
_aPhospholipases A _xanalysis |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 |
_aSplanchnic Circulation _xphysiology |
| 700 | 1 | _ade Waart, D R | |
| 700 | 1 | _aStruijk, D G | |
| 700 | 1 | _aKrediet, R T | |
| 773 | 0 |
_tThe Journal of laboratory and clinical medicine _gvol. 132 _gno. 4 _gp. 329-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-2143(98)90047-6 _zAvailable from publisher's website |
| 999 |
_c9759178 _d9759178 |
||